<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37357209</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0253-9624</ISSN><JournalIssue CitedMedium="Print"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title><ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Associations between vitamin D levels and systemic lupus erythematosus risk:a Mendelian randomized study].</ArticleTitle><Pagination><StartPage>891</StartPage><EndPage>898</EndPage><MedlinePgn>891-898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112150-20220622-00643</ELocationID><Abstract><AbstractText><b>Objective:</b> To explore the causal effects of the serum Vitamin D levels on the risk of systemic lupus erythematosus (SLE). <b>Methods:</b> A two-sample Mendelian randomization (MR) study was performed to infer the causality. Three Genome-wide association studies (GWAS) for circulating Vitamin D levels, including 25-hydroxyvitamin D [25(OH)D], 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>] and C3-epimer of 25-hydroxyvitamin D<sub>3</sub> [C3-epi-25(OH)D<sub>3</sub>] published in 2020, and one GWAS for SLE published in 2015 were utilized to analyze the causal effects of the serum Vitamin D levels on the risk of SLE. MR analyses were conducted using the inverse-variance weighted method (IVW), weighted median, MR-Egger methods, MR-pleiotropy residual sum and outlier (MR-PRESSO) method. <b>Results:</b> 34, 29 and 6 SNPs were respectively selected as instrumental variables to analyze the causal association of total 25 (OH) D level, 25 (OH) D<sub>3</sub> level and C3-epi-25 (OH) D<sub>3</sub> level with the risk of SLE. The MR results showed that each standard deviation decrease in the level of 25(OH)D<sub>3</sub> would result in 14.2% higher risk of SLE (<i>OR</i>, 0.858; 95%<i>CI</i>, 0.753-0.978; <i>P</i>=0.022). The levels of 25(OH)D and C3-epi-25(OH)D<sub>3</sub> had null associations with risk of SLE (<i>OR</i>, 0.849; 95%<i>CI</i>, 0.653-1.104; <i>P</i>=0.222; <i>OR</i>, 0.904; 95%<i>CI</i>, 0.695-1.176; <i>P</i>=0.452). <b>Conclusion:</b> This study have identified a causal effect of 25(OH)D<sub>3</sub> on increased risk of SLE. These findings highlighted the significance of active monitoring and prevention of SLE in population of low Vitamin D levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Y Q</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Institute of Skin Health, China-Japan Friendship Hospital, Beijing 100029, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>81872520, 82173418, 81872516</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>201920102303</GrantID><Agency>Dermatology Talent Training Platform Construction Project of Chinese Academy of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7904962</NlmUniqueID><ISSNLinking>0253-9624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x63a2;&#x8ba8;&#x7ef4;&#x751f;&#x7d20;D&#x6c34;&#x5e73;&#x4e0e;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#xff08;SLE&#xff09;&#x60a3;&#x75c5;&#x98ce;&#x9669;&#x4e4b;&#x95f4;&#x7684;&#x56e0;&#x679c;&#x5173;&#x7cfb;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x91c7;&#x7528;&#x53cc;&#x6837;&#x672c;&#x5b5f;&#x5fb7;&#x5c14;&#x968f;&#x673a;&#x5316;&#xff08;MR&#xff09;&#x7814;&#x7a76;&#x65b9;&#x6cd5;&#xff0c;&#x5229;&#x7528;2020&#x5e74;&#x53d1;&#x8868;&#x7684;&#x603b;25-&#x7f9f;&#x7ef4;&#x751f;&#x7d20;D&#x6c34;&#x5e73;&#xff3b;25&#xff08;OH&#xff09;D&#xff3d;&#x3001;25-&#x7f9f;&#x7ef4;&#x751f;&#x7d20;D<sub>3</sub>&#x6c34;&#x5e73;&#xff3b;25&#xff08;OH&#xff09;D<sub>3</sub>&#xff3d;&#x3001;25-&#x7f9f;&#x7ef4;&#x751f;&#x7d20;D<sub>3</sub>&#x5dee;&#x5411;&#x5f02;&#x6784;&#x4f53;&#x6c34;&#x5e73;&#xff3b;C3-epi-25&#xff08;OH&#xff09;D<sub>3</sub>&#xff3d;&#x7b49;&#x5faa;&#x73af;&#x7ef4;&#x751f;&#x7d20;D&#x6c34;&#x5e73;&#x76f8;&#x5173;&#x7684;3&#x4e2a;&#x5168;&#x57fa;&#x56e0;&#x7ec4;&#x5173;&#x8054;&#x5206;&#x6790;&#xff08;GWAS&#xff09;&#x6570;&#x636e;&#x96c6;&#x548c;2015&#x5e74;&#x53d1;&#x8868;&#x7684;1&#x4e2a;SLE GWAS&#x6570;&#x636e;&#x96c6;&#xff0c;&#x901a;&#x8fc7;&#x9006;&#x65b9;&#x5dee;&#x52a0;&#x6743;&#x6cd5;&#xff08;IVW&#xff09;&#x3001;&#x52a0;&#x6743;&#x4e2d;&#x4f4d;&#x6570;&#x6cd5;&#xff08;WME&#xff09;&#x3001;MR-Egger&#x6cd5;&#x3001;MR&#x591a;&#x6548;&#x6b8b;&#x5dee;&#x548c;&#x79bb;&#x7fa4;&#x503c;&#x6cd5;&#xff08;MR-PRESSO&#xff09;&#x5206;&#x6790;&#x7ef4;&#x751f;&#x7d20;D&#x6c34;&#x5e73;&#x5bf9;SLE&#x60a3;&#x75c5;&#x98ce;&#x9669;&#x7684;&#x56e0;&#x679c;&#x6548;&#x5e94;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> &#x5206;&#x6790;&#x603b;25&#xff08;OH&#xff09;D&#x6c34;&#x5e73;&#x3001;25&#xff08;OH&#xff09;D<sub>3</sub>&#x6c34;&#x5e73;&#x548c;C3-epi-25&#xff08;OH&#xff09;D<sub>3</sub>&#x6c34;&#x5e73;&#x4e0e;SLE&#x60a3;&#x75c5;&#x98ce;&#x9669;&#x56e0;&#x679c;&#x5173;&#x8054;&#x7684;&#x6709;&#x6548;&#x5de5;&#x5177;&#x53d8;&#x91cf;&#x5206;&#x522b;&#x4e3a;34&#x3001;29&#x548c;6&#x4e2a;SNP&#x4f4d;&#x70b9;&#x3002;MR&#x5206;&#x6790;&#x7ed3;&#x679c;&#x663e;&#x793a;&#xff0c;25&#xff08;OH&#xff09;D<sub>3</sub>&#x6c34;&#x5e73;&#x6bcf;&#x964d;&#x4f4e;&#x4e00;&#x4e2a;&#x6807;&#x51c6;&#x5dee;&#xff0c;SLE&#x98ce;&#x9669;&#x589e;&#x52a0;14.2%&#xff08;<i>OR</i>&#xff0c;0.858&#xff1b;95%<i>CI</i>&#xff0c;0.753~0.978&#xff1b;<i>P</i>=0.022&#xff09;&#xff0c;&#x800c;&#x603b;25&#xff08;OH&#xff09;D&#x6c34;&#x5e73;&#x548c;C3-epi-25&#xff08;OH&#xff09;D<sub>3</sub>&#x6c34;&#x5e73;&#x4e0e;SLE&#x98ce;&#x9669;&#x7684;&#x56e0;&#x679c;&#x5173;&#x8054;&#x4e0d;&#x5177;&#x6709;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>OR</i>&#xff0c;0.849&#xff1b;95%<i>CI</i>&#xff0c;0.653~1.104&#xff1b;<i>P</i>=0.222&#xff1b;<i>OR</i>&#xff0c;0.904&#xff1b;95%<i>CI</i>&#xff0c;0.695~1.176&#xff1b;<i>P</i>=0.452&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> 25&#xff08;OH&#xff09;D<sub>3</sub>&#x4e0e;SLE&#x60a3;&#x75c5;&#x98ce;&#x9669;&#x5b58;&#x5728;&#x56e0;&#x679c;&#x5173;&#x8054;&#xff0c;&#x63d0;&#x793a;&#x4f4e;&#x7ef4;&#x751f;&#x7d20;D&#x4eba;&#x7fa4;&#x5e94;&#x79ef;&#x6781;&#x76d1;&#x6d4b;&#x5e76;&#x6ce8;&#x610f;&#x9884;&#x9632;SLE&#x53d1;&#x751f;&#xff0c;SLE&#x60a3;&#x8005;&#x5e94;&#x9002;&#x5f53;&#x8865;&#x5145;25&#xff08;OH&#xff09;D<sub>3</sub>&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>25</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37357209</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112150-20220622-00643</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>